XT
ZYBT

XTX Topco’s Zhengye Biotechnology Holding ZYBT Stock Holding History

XTX Topco’s Portfolio ZYBT Stock Details ZYBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.1K Buy
48,865
+4,719
+11% +$4.22K ﹤0.01% 3808
2026
Q1 		$41.3K Sell
44,146
-15,140
-26% -$14.2K ﹤0.01% 3371
2025
Q4 		$68.2K Buy
59,286
+24,697
+71% +$54.7K ﹤0.01% 2751
2025
Q3 		$90.6K Buy
+34,589
New +$240K ﹤0.01% 2043

Other funds holding ZYBT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

XTX Topco's ZYBT Position: Q2 2026 in Review

XTX Topco increased its Zhengye Biotechnology Holding (ZYBT) stake by 11% in Q2 2026, buying an estimated $4.22K and bringing the position to 48,865 shares worth $33.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3808.

XTX Topco first reported a position in ZYBT in Q3 2025 and has held it in 4 quarters since. The position peaked at $90.6K in Q3 2025. 8 funds tracked by Wall St. Rank hold ZYBT as of Q2 2026.

  • XTX Topco held 48,865 shares of Zhengye Biotechnology Holding worth $33.1K as of Q2 2026.
  • XTX Topco bought 4,719 Zhengye Biotechnology Holding shares in Q2 2026, an estimated $4.22K.
  • Zhengye Biotechnology Holding made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3808 holding.
  • XTX Topco first reported a position in Zhengye Biotechnology Holding in Q3 2025 and has held it in 4 quarters since.
  • XTX Topco's Zhengye Biotechnology Holding position peaked at $90.6K in Q3 2025.
  • 8 funds tracked by Wall St. Rank held Zhengye Biotechnology Holding as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.